A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment
Clinical trial NCT06247085 · RECRUITING
Trial details
- NCT number
- NCT06247085
- Sponsor
- Travere Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-28
- Primary completion
- 2027-08-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.